- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guard Therapeutics International AB (GUARD)
Guard Therapeutics International AB stock price live, this page displays ST GUARD stock exchange data. View the GUARD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guard Therapeutics International AB real time stock price chart below.
What Is the Guard Therapeutics International AB Stock Price Today?
The Guard Therapeutics International AB stock price today is 1.86.
What Is the Stock Symbol for Guard Therapeutics International AB?
The stock symbol for Guard Therapeutics International AB is "GUARD."
What Stock Exchange Does Guard Therapeutics International AB Trade On?
Guard Therapeutics International AB is listed and trades on the Stockholm stock exchange.
Is Guard Therapeutics International AB a Good Stock to Buy?
Determining whether Guard Therapeutics International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GUARD quote. (ISIN: SE0021181559)
What Is the Guard Therapeutics International AB Stock Price Today?
The Guard Therapeutics International AB stock price today is 1.86.
What Is the Stock Symbol for Guard Therapeutics International AB?
The stock symbol for Guard Therapeutics International AB is "GUARD."
What Stock Exchange Does Guard Therapeutics International AB Trade On?
Guard Therapeutics International AB is listed and trades on the Stockholm stock exchange.
Is Guard Therapeutics International AB a Good Stock to Buy?
Determining whether Guard Therapeutics International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GUARD quote. (ISIN: SE0021181559)
Stockholm
Currency in SEK
1.86
-0.04(-2.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.86
1.94
52 wk Range
1.10
34.80
GUARD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.861.94
52 wk Range
1.1034.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GUARD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Guard Therapeutics International AB Company Profile
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. The company’s pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides, that is in preclinical studies for the treatment of CKD and diabetes, heart failure, alport syndrome, sickle-cell nephropathy, and preeclampsia. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
Compare GUARD to Peers and Sector
Metrics to compare | GUARD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGUARDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −3.4x | −0.6x | |
PEG Ratio | −0.03 | −0.05 | 0.00 | |
Price/Book | 0.7x | 5.2x | 2.6x | |
Price / LTM Sales | - | 0.0x | 3.4x | |
Upside (Analyst Target) | −6.4% | 257.1% | 44.9% | |
Fair Value Upside | Unlock | −14.2% | 6.7% | Unlock |
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-1.29 / --
Revenue / Forecast
-- / --
FAQ
What Is the Guard Therapeutics (GUARD) Stock Price Today?
The Guard Therapeutics stock price today is 1.86
What Stock Exchange Does Guard Therapeutics Trade On?
Guard Therapeutics is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Guard Therapeutics?
The stock symbol for Guard Therapeutics is "GUARD."
What Is the Guard Therapeutics Market Cap?
As of today, Guard Therapeutics market cap is 37.41M.
What Is Guard Therapeutics's Earnings Per Share (TTM)?
The Guard Therapeutics EPS (TTM) is -7.38.
When Is the Next Guard Therapeutics Earnings Date?
Guard Therapeutics will release its next earnings report on Feb 20, 2026.
From a Technical Analysis Perspective, Is GUARD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Guard Therapeutics Stock Split?
Guard Therapeutics has split 10 times.
How Many Employees Does Guard Therapeutics Have?
Guard Therapeutics has 12 employees.
What is the current trading status of Guard Therapeutics (GUARD)?
As of Jan 31, 2026, Guard Therapeutics (GUARD) is trading at a price of 1.86, with a previous close of 1.90. The stock has fluctuated within a day range of 1.86 to 1.94, while its 52-week range spans from 1.10 to 34.80.
What Is Guard Therapeutics (GUARD) Price Target According to Analysts?
The average 12-month price target for Guard Therapeutics is SEK1.75, with a high estimate of SEK1.75 and a low estimate of SEK1.75. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -5.91% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.